Drugs
EPALINGES, SWITZERLAND: - Grant E. Pickering named President and CEO - Dr. Christopher Henney appointed Chairman of the Board of Directors - Election of new members to the Board of Directors ...
PARSIPPANY, NJ: Conference Call to Be Held at 8:30 a.m. Eastern Time ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 04/09/12 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), Inc., a biotechnology company leveraging significant government funding to develop a p ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 04/06/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the resignation of Trevor M. Jones, Ph.D., C.B.E., from the Board of Directors. Prof. Jone ...
AURORA, ON: AURORA, ON -- (Marketwire) -- 04/05/12 -- Helix BioPharma Corp. (TSX: HBP) (NYSE Amex: HBP) (FRANKFURT: HBP), announced today that its recently reconstituted Board of Directors has met and commenced ...
MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 04/05/12 -- Aeolus Pharmaceuticals (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform of no ...
BALTIMORE, MD: BALTIMORE, MD -- (Marketwire) -- 04/04/12 -- , a biopharmaceutical company focused on the discovery, development and commercialization of prescription pharmaceuticals whose primary activity is in th ...
WOODBRIDGE, ONTARIO: WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/03/12 -- Pivotal Therapeutics Inc. (CNSX: PVO)(OTCQX: PVTTF), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease, is ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 04/02/12 -- NuPathe Inc. (NASDAQ: PATH), a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the ...
WOODBRIDGE, ONTARIO: WOODBRIDGE, ONTARIO -- (Marketwire) -- 04/02/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease has granted a tot ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 03/30/12 -- (OTCBB: KDUS) announced today financial results for the full year ended December 31, 2011.Revenues for the full year 2011 were $0, compared to $100,000 fo ...
BOTHELL, WA: BOTHELL, WA -- (Marketwire) -- 03/30/12 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based therapeutics, today announced the presentation of data from the Company's infectious dise ...
BRIDGEWATER, NJ: BRIDGEWATER, NJ -- (Marketwire) -- 03/29/12 -- today announced that it will seek to enter into a $200 million Senior Secured Incremental Term Loan B credit facility to fund prepayment of its existi ...
PRINCETON, NJ: CEO to Provide Insights on the BioPharma Industry and Agile Therapeutics' Commercialization Plans ...
REDWOOD CITY, CA: Results to Be Included in APF530 New Drug Application Resubmission Targeted for Mid-2012 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 03/23/12 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB) (the "Company") is pleased to announce that on March 2 ...
TORONTO, ONTARIO: University of Miami Miller School of Medicine Report Supports Value of Food Intolerance Testing ...
NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 03/21/12 -- Novo Energies Corporation ("Novo") (OTCBB: NVNC) today announced that Immunovative Therapies, Ltd. ("Immunovative") is preparing to la ...
MADISON, NJ: MADISON, NJ -- (Marketwire) -- 03/20/12 -- Reimbursement Intelligence, the New Jersey-based market research firm helping biopharma, medical device and diagnostics firms succeed in managed markets, a ...
CONSHOHOCKEN, PA: Resubmission of Migraine Patch NDA Remains on Track for the First Half of 2012 ...
